SUTUREGARD® Medical and Federated Healthcare Supply Sign Non-Exclusive Distribution Deal

SUTUREGARD® Medical, Inc. Blog

 
28Jul

Press Release - SUTUREGARD® Medical and Federated Healthcare Supply Sign Non-Exclusive Distribution Deal

SUTUREGARD® Medical has formed a non-exclusive distribution partnership with Federated Healthcare Supply to expand market reach of the HEMIGARD® ARS device and the SUTUREGARD® ISR device which are patented wound closure technologies that simplify complex and challenging wound closures.

The relationship began after Federated Healthcare Supply approached SUTUREGARD® Medical with customer demand. "We were contacted by Federated Healthcare Supply because some of their loyal customers wanted to purchase our products", said Jen Akeroyd, PhD, RN, COO of SUTUREGARD® Medical. "We have been impressed by Federated's high touch customer experience which mimics our approach. We strive to get to know our customers so that we can offer a tailored experience", said Jen.

Federated Healthcare Supply Holdings is one of the largest, independent healthcare distributors in the United States. Federated Healthcare Supply serves as a sales and service organization for healthcare products for both healthcare professionals and individuals. They take pride as an independent distributor ensuring they work with the best known healthcare manufacturers, keep an extensive inventory, and maintain a team with extreme expertise.

SUTUREGARD® Medical is pleased to announce this new partnership with Federated Healthcare Supply, looking forward to a future long-lasting partnership.

Based in Corvallis, Oregon, SUTUREGARD® Medical, Inc is a private company offering novel medical devices for surgeons to repair challenging surgical defects more simply. SUTUREGARD® medical devices are intended to provide minimal wound trauma and reduce the healing period after surgery, providing better results for patients and providers.

Related

Next Generation Suture Retention Bridges

Suture retention bridges support the primary closure location & reduce the risk of wound dehiscence....

Read More >

Bill Lear, MD, Discusses Development of HEMIGARD ARS

Bill Lear, MD, Mohs surgeon now but 5-year emergency physician previously, talks with Dr. Mark Plast...

Read More >

The Deeper Meaning of a Successful Sales Launch

Sales are proven traction. Investors love it. But for inventors, sales have a deeper, transformation...

Read More >

Reducing the Impact of Pretibial Lacerations

Thin fragile skin can occur with age, severe sun damage or chronic steroid use. Often, they are on b...

Read More >

Press Release - SUTUREGARD® Medical, INC. is Presenting at the American Society of Plastic Surgery Annual Meeting

SUTUREGARD® is pleased to announce CEO, Dan Ladizinsky, MD, will be presenting for the second time a...

Read More >

You have a skin cancer for which your doctor recommends Mohs surgery. What is Mohs Surgery?

First, let’s back up. Tissue is sent for pathology to answer one of two questions: “what is it?” ...

Read More >

Relax & Close, More Wounds, More Simply.

Making wound closure easier for surgeons and better for patients.

Order Now